Study of KW-0761 in Subjects With CCR4-positive Peripheral T/NK-cell Lymphoma

NCT01192984 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral T/NK-cell Lymphoma

Interventions

BIOLOGICAL: KW-0761

Sponsor

Kyowa Kirin Co., Ltd.